5 May 2016 - Deborah Wilkes
Archived
GlaxoSmithKline's board will only consider whether the company should split off Consumer Healthcare once profitability at the business has been improved, according to chairman Philip Hampton.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.